- Home
- / Vitruvia Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Vitruvia Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.4
2024-10-29
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|
| Revenue | 5.6M | 1.9M | 1.4M | 1.8M | |
| Cost of goods sold | 3.7M | 833.0K | 377.0K | 427.0K | |
| Gross profit | 2.0M | 1.1M | 1.1M | 1.3M | |
| Gross profit margin, % | 36.2% | 58.2% | 76.0% | ||
| Operating expense total | 3.0M | 1.8M | 2.1M | 1.3M | 119.0K |
| Depreciation and amortization | 352.0K | 432.0K | 432.0K | 431.0K | |
| EBITDA | (961.0K) | (695.0K) | (913.0K) | 61.0K | (119.0K) |
| EBITDA margin, % | -17.2% | -35.7% | 3.5% | ||
| EBIT | (1.3M) | (8.1M) | (1.4M) | (370.0K) | (119.0K) |
| EBIT margin, % | -23.5% | -415.0% | -21.1% | ||
| Interest income | 9.0K | ||||
| Interest expense | 184.0K | 50.0K | 28.0K | 134.0K | 75.0K |
| Pre tax profit | (1.5M) | (8.1M) | (1.5M) | (504.0K) | (171.0K) |
| Income tax expense | 48.0K | 1.0K | 18.0K | 31.0K | 3.0K |
| Net Income | (1.5M) | (8.1M) | (1.5M) | (535.0K) | (174.0K) |